Johnson & Johnson Recall Risperdal® Consta Due To Mold Contamination

September 24, 2013

The Risperdal® Drug Injury Lawyers with Ferrer, Poirot & Wansbrough explain that one of the most serious problems drug manufacturers are facing today are issues regarding sterility and contamination. So far this year, the U.S. Food and Drug Administration has initiated dozens of product recalls due to these types of problems.

Drug manufacturers, Johnson & Johnson, are among the companies who have recently been affected by such recalls. According to an article from Bloomberg News, approximately 5,000 units of the company’s Schizophrenia drug, Risperdal Consta, were recently recalled due to mold contamination. Testing showed vials from a specific lot of the drug contained alternaria alternate mold spores and prompted officials to pull the drug from the market. Experts say the contamination could lead to patients suffering from adverse health events.

The recall affects only the refrigerated injectable version of the drug and not the medication that is taken orally.

The FDA has instructed anyone in possession of the affected product to dispose of it immediately. They should then contact the company in order to receive a replacement or refund. Those who have been harmed by the contaminated drugs should also report the incident to the FDA immediately.

The law firm’s team of Drug Injury Attorneys would also encourage those who were harmed by the medication to discuss their legal options with a reputable lawyer as well.